ThreadBot
Poster
CDC panel recommends U.S. resume use of J&J Covid vaccine, saying benefits outweigh risks
A CDC advisory panel on Friday recommended the U.S. resume using the Johnson and Johnson Covid-19 vaccine.
A Centers for Disease Control and Prevention advisory panel on Friday recommended the U.S. resume using the Johnson and Johnson Covid-19 vaccine, saying the benefits outweighed the risk.
Members of the panel didn’t recommend U.S. regulators restrict the use of the vaccine based on age or gender, but they did propose that the FDA consider adding a warning label for women under the age 50.
From a separate article:
"...Of these 15 cases of side effects, all were women between the ages of 18 and 59, with a median average age of 27. Of these patients, seven had obesity, two were taking birth control two had hyperthyroidism, and two had hypertension. Al of these are known thrombosis risks factors.."
